CPC A61L 27/34 (2013.01) [A61F 2/0063 (2013.01); A61L 27/16 (2013.01); A61L 27/24 (2013.01); A61L 27/362 (2013.01); A61L 27/3687 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61F 2210/0004 (2013.01); A61L 2300/254 (2013.01)] | 20 Claims |
1. A method of treatment, comprising:
selecting a medical device comprising an implant main body portion comprising a collagen-containing tissue matrix having a surface region that has been treated with a transglutaminase coating, and wherein the treated surface region provides at least one of an anti-adhesion or anti-abrasion property to the tissue matrix; and
implanting the medical device into or on an anatomic site.
|